Showing posts with label abdominal. Show all posts
Showing posts with label abdominal. Show all posts

Friday, May 29, 2015

Antibiotic approved for treating infant abdominal infections

The antibiotic was approved by the U. S. Food and Drug Administration for treating abdominal infections in children less than 3 months of age. The approval came after a study by a National Institutes of Health research network evaluated the drug in treating children in this age group.
The May 28 issue of The Federal Register described the study which supported the approval of meropenem for “complicated intra-abdominal infections” in children under 3 months of age. Among preterm infants, intestinal perforation or leakage — which is part of complicated intra-abdominal infection — may be life threatening. The study was undertaken under the terms of the Best Pharmaceuticals for Children Act, which directed NIH to conduct studies on drugs used in children but not previously tested in children or in specific pediatric age groups.
Meropenem is a broad spectrum antibiotic — effective against a wide variety of bacteria. The drug has been previously approved to treat complicated intra-abdominal infections and complicated skin infections in adults and older children, and for treating children 3 months of age and older with bacterial meningitis — an infection of the fluid bathing the brain and spinal cord. During the last several years, physicians have begun prescribing meropenem for preterm infants with serious abdominal infections. Because they lacked an effective alternative, many physicians had prescribed the drug for a use other than what the FDA had approved. The NIH study was undertaken in response to a written request from the FDA to evaluate the dosing and safety of meropenem in the treatment of complicated intra-abdominal infections in infants under 3 months of age.
“This study shows that meropenem is appropriate for treating complicated intra-abdominal infections in very young infants. In addition, we now have dosing guidelines for various age groups of premature infants,” said Anne Zajicek, M.D., Pharm.D., chief of the Obstetric and Pediatric Pharmacology and Therapeutics Branch at NIH’s Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which funded the study.
Dr. Zajicek explained that physicians often need to extrapolate from studies of adults when prescribing for pediatric patients, because many drugs have never been tested specifically for use in children. However, because of their smaller size, differences in metabolism, and other physical differences from adults, many drugs may affect children differently than they do adults. Under the Best Pharmaceuticals for Children Act, NICHD works with FDA to identify drugs not tested in children to determine if they are appropriate for use in children.
The NICHD commissioned the study to investigate meropenem use in 200 infants under 3 months of age, including premature infants. Researchers examined how the drug was absorbed and distributed throughout the body, and used that information to develop dosing recommendations for different age groups of infants, including premature infants of different ages. In addition, the study evaluated side effects. Based on this study, treatment of infants with meropenem was safe and was not associated with increased risk for serious side effects.

Friday, May 22, 2015

Weight Loss Research: Thunder god vine potential obesity treatment ♦ Skipping meals linked to abdominal weight gain ♦ Potential obesity treatment targets

Potential obesity treatment targets the two sides of appetite: Hunger and feeling full Our bodies' hormones work together to tell us when to eat and when to stop. But for many people who are obese, this system is off-balance. Now scientists have designed a hormone-like compound to suppress hunger and boost satiety, or a full feeling, at the same time. Obese mice given the compound for 14 days had a tendency to eat less than the other groups.
Average-sized models could sell more fashion The fashion industry could benefit from using average-sized models rather than size zero in marketing campaigns.The study considered the impact of using average and zero-sized models in marketing campaigns.
Skipping meals linked to abdominal weight gain Skipping meals sets off a series of metabolic miscues that can result in abdominal weight gain. In the study, mice that ate all of their food as a single meal and fasted the rest of the day developed insulin resistance in their livers -- which scientists consider a telltale sign of prediabetes..
Thunder god vine used in traditional Chinese medicine is a potential obesity treatment An extract from the thunder god vine, which has a long history of use in traditional Chinese medicine, reduces food intake and causes up to a 45 percent decrease in body weight in obese mice. The weight-loss compound, called Celastrol, produces its potent effects by enhancing the action of an appetite-suppressing hormone called leptin..
Obesity, weight loss change splicing pattern of obesity, type 2 diabetes genes Alternative splicing of obesity and type 2 diabetes related genes may contribute to the pathophysiology of obesity, according to research. Obesity leads to changes in the splicing pattern of metabolically relevant genes such as TCF7L2 and INSR, resulting in impaired insulin action. However, weight loss, induced by either obesity surgery or a very low-calorie diet, reverses these changes

Friday, March 27, 2015

Health News: Nanoparticle therapy promotes wound healing ♦ Preserving milk using pulsed electric field processing ♦ Laparoscopic hysterectomy may be safer

Nanoparticle therapy promotes wound healing  An experimental therapy successfully tested in mice cut in half the time it takes to heal wounds compared to no treatment at all. "We envision that our nanoparticle therapy could be used to speed the healing of all sorts of wounds,  Continue Reading
Preserving milk using energy efficient pulsed electric field processing  High voltage, short pulsed electric fields selectively damage cell membrane directly killing the contaminating bacteria by a process known as electroporation. Continue Reading
Laparoscopic hysterectomy may be safer than abdominal procedure  A study has compared the relative risks of laparoscopic hysterectomy (with morcellation) with abdominal surgery for hysterectomy in premenopausal women for presumed uterine fibroids. Examining short- and long-term complications,they found that abdominal surgery carries a higher risk of complications Continue Reading
Malaria-infected cells produce odors attractive to mosquitoes   The malaria parasite Plasmodium falciparum produces chemical compounds called terpenes that give off odors that attract mosquitoes, according to new research. The study might explain why the insects are more likely to bite humans or animals infected with the organism. Continue Reading
Soils retain radioactivity in Fukushima  The soil's physical and chemical properties in rice fields around the Fukushima site have been the focus of recent study. Researchers examined factors affecting soil-to-plant transfer of radioactive cesium in the Fukushima area. Continue Reading